US Broker Ratings

iRadimed Corporation (IRMD) Stock Analysis: Navigating Growth with a 23.75% Return on Equity

iRadimed Corporation (IRMD) is carving a notable niche in the healthcare sector, specifically within the medical devices industry. Headquartered in Winter Springs, Florida, this U.S.-based company is a prominent player..

Community Health Systems, Inc. (CYH) Stock Analysis: Will Healthcare Challenges Turn into a 16% Upside?

Community Health Systems, Inc. (NYSE: CYH), a stalwart in the healthcare sector, operates a network of acute care hospitals across the United States. With a current market cap of $428.76..

Xencor, Inc. (XNCR) Stock Analysis: Biotech Innovator with 72% Upside Potential

Xencor, Inc. (NASDAQ: XNCR) is a promising player in the biotechnology sector, particularly for investors with an appetite for growth and innovation in healthcare. With a market capitalization of $1.07..

Bioventus Inc. (BVS) Stock Analysis: A Healthcare Gem with 113% Potential Upside

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, has emerged as a compelling opportunity for investors seeking exposure in the medical devices industry. Headquartered in Durham, North..

Neuropace, Inc. (NPCE) Investor Outlook: Analyst Consensus Points to a 57% Potential Upside

Neuropace, Inc. (NASDAQ: NPCE), a pioneering company in the medical devices sector, commands attention with its innovative approach to treating drug-resistant focal epilepsy. Based in Mountain View, California, Neuropace has..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Assessing the 15.36% Upside Potential and Strong Analyst Ratings

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a prominent player in the biotechnology sector, is attracting significant attention with its robust pipeline focused on neurodegenerative diseases and other rare conditions. Headquartered in..

Mind Medicine (MNMD) Stock Analysis: A Biotech Play with Over 100% Potential Upside

For investors with an eye on the biotechnology sector, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) presents an intriguing opportunity. As a clinical-stage biopharmaceutical company focused on pioneering treatments for brain..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Healthcare Staffing Challenges with a Potential 3.22% Upside

AMN Healthcare Services Inc (AMN), a prominent player in the medical care facilities sector, offers technology-enabled healthcare workforce solutions across the United States. With a market capitalization of $763.8 million,..

Relay Therapeutics, Inc. (RLAY) Investor Outlook: Analyzing the 108.91% Potential Upside in Biotech Innovation

Relay Therapeutics, Inc. (NASDAQ: RLAY) has emerged as a compelling player in the biotechnology sector, captivating investor interest with its innovative approach to drug discovery and development. Headquartered in Cambridge,..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring an 85.95% Potential Upside

For investors with an eye on the biotechnology sector, Arvinas, Inc. (NASDAQ: ARVN) presents an intriguing opportunity, especially given its potential upside of 85.95%. The company, specializing in the promising..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 17% Potential Upside in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, specializes in providing home health and hospice services across the United States. With a market capitalization of $406.03 million,..

GH Research PLC (GHRS) Stock Analysis: Exploring a Promising 124.99% Upside Potential

For investors keen on the biotechnology sector, GH Research PLC (NASDAQ: GHRS) offers an intriguing opportunity with substantial upside potential. Based in Dublin, Ireland, this clinical-stage biopharmaceutical firm is making..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 130.95% Potential Upside in the Medical Devices Sector

CeriBell, Inc. (NASDAQ: CBLL), a burgeoning name in the healthcare sector, particularly in medical devices, has been capturing the attention of investors due to its promising growth potential and innovative..

Definitive Healthcare Corp. (DH) Stock Analysis: Evaluating a 54.86% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH) is a notable player in the Health Information Services industry, offering a sophisticated software as a service (SaaS) healthcare commercial intelligence platform. With its roots..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Potential 166.54% Upside

Investors seeking opportunities in the biotech sector may find Kura Oncology, Inc. (NASDAQ: KURA) an intriguing prospect. Headquartered in San Diego, California, this clinical-stage biopharmaceutical company is focused on developing..

Eton Pharmaceuticals, Inc. (ETON): Exploring a 63.58% Upside Potential and Analyst Ratings

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Based in the United States, this Deer Park, Illinois..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 47.85% Upside Potential

AxoGen, Inc. (AXGN), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive potential upside of 47.85%. As a leader in peripheral..

Cronos Group Inc. (CRON) Stock Analysis: Is the Current Price a Buying Opportunity Despite a -17% Potential Downside?

Investors eyeing the cannabis industry often find themselves considering Cronos Group Inc. (NASDAQ: CRON), a key player in the cannabinoid space with a growing international footprint. With a market capitalization..

InMode Ltd. (INMD) Stock Analysis: A Closer Look at Its Growth Potential and Market Position

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has been making waves with its innovative aesthetic medical products. Headquartered in Yokne’am,..

Evolus, Inc. (EOLS) Stock Analysis: Unraveling a Potential 198% Upside in the Aesthetic Healthcare Market

Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic segment, is making waves in the aesthetic market. With its flagship..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds